Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · IEX Real-Time Price · USD
3.550
+0.020 (0.57%)
At close: May 17, 2024, 4:00 PM
3.700
+0.150 (4.23%)
After-hours: May 17, 2024, 7:21 PM EDT
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $151.11 million as of May 17, 2024. Its market cap has decreased by -64.42% in one year.
Market Cap
151.11M
Enterprise Value
-83.12M
1-Year Change
-64.42%
Ranking
Category
Stock Price
$3.55
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $1.05B to $151.11M, a decrease of -85.60%. That is a compound annual growth rate of -39.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 150.70M | 0.60% |
May 16, 2024 | 149.80M | -1.12% |
May 15, 2024 | 151.50M | -3.26% |
May 14, 2024 | 156.60M | -0.25% |
May 13, 2024 | 157.00M | 5.65% |
May 10, 2024 | 148.60M | -3.82% |
May 9, 2024 | 154.50M | -3.98% |
May 8, 2024 | 160.90M | 15.59% |
May 7, 2024 | 139.20M | -2.93% |
May 6, 2024 | 143.40M | -1.44% |
May 3, 2024 | 145.50M | 2.97% |
May 2, 2024 | 141.30M | 1.51% |
May 1, 2024 | 139.20M | 6.42% |
Apr 30, 2024 | 130.80M | -3.11% |
Apr 29, 2024 | 135.00M | - |
Apr 26, 2024 | 135.00M | 1.58% |
Apr 25, 2024 | 132.90M | -4.53% |
Apr 24, 2024 | 139.20M | -1.76% |
Apr 23, 2024 | 141.70M | 3.05% |
Apr 22, 2024 | 137.50M | 3.46% |
Apr 19, 2024 | 132.90M | 4.32% |
Apr 18, 2024 | 127.40M | -5.91% |
Apr 17, 2024 | 135.40M | -3.90% |
Apr 16, 2024 | 140.90M | -3.76% |
Apr 15, 2024 | 146.40M | -4.94% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
TELA Bio | 156.32M |
ProQR Therapeutics | 155.17M |
CytomX Therapeutics | 155.06M |
Sagimet Biosciences | 153.19M |
BioAtla | 151.53M |
Harvard Bioscience | 150.05M |
Electromed | 148.45M |
Syros Pharmaceuticals | 146.74M |